β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria
Authors:
- 11 December 2018
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (4) , 5687-5694
Abstract
In this article, we aim to examine the novel effects of β‐sitosterol on murine experimental colitis. β‐Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF‐α, IL‐6, and IL‐1β in intestinal tissue of mice with experimental colitis in a concentration‐dependent manner. β‐Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular Salmonella typhimurium. These results showed the multiple effects of β‐sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.Keywords
This publication has 21 references indexed in Scilit:
- Role of Antimicrobial Peptides in Inflammatory Bowel DiseasePolymers, 2011
- Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel diseaseTherapeutic Advances in Gastroenterology, 2011
- Dysbiosis in Inflammatory Bowel Disease: A Link With Antimicrobial Peptides Secretion?Gastroenterology, 2011
- β-Sitosterol: Supercritical Carbon Dioxide Extraction from Sea Buckthorn (Hippophae rhamnoides L.) SeedsInternational Journal of Molecular Sciences, 2010
- Inflammatory bowel diseaseInflammatory Bowel Diseases, 2009
- Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4+ CD45RBhigh T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activationClinical Immunology, 2007
- Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunitiesInflammatory Bowel Diseases, 2006
- Azathioprine in inflammatory bowel disease, a safe alternative?Mediators of Inflammation, 1998
- Cyclosporine Treatment of Inflammatory Bowel DiseaseMayo Clinic Proceedings, 1992
- Anti-Inflammatory and Antipyretic Activities of β-SitosterolPlanta Medica, 1980